ALK Deletion Exons 2 to 19: Case Report of a Rare ALK Inhibitor–Responsive Lung Cancer Driver Oncogene

ALK internal deletions of nonkinase domain exons occur in 0.01% of lung cancers with ALK genomic aberrations. We report a lung adenocarcinoma with a previously undescribed somatic ALK deletion of exons 2 to 19 with dramatic and sustained (>23 mo) response to alectinib. Our and other reported cases w...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zachary R. Schoepflin, MD, Emmeline Academia, PharmD, Soravis A. Osataphan, MD, Deepa Rangachari, MD, Sheida Sharifi, MD, PhD, Paul A. VanderLaan, MD, PhD, Daniel B. Costa, MD, PhD
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-04-01
Col·lecció:	JTO Clinical and Research Reports
Matèries:	Lung cancer ALK Deletion Alectinib Case report
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666364323000280
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!